Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark E. Strome files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Urioste George de - $182K in BEAT purchases and sales in the last 12 months
- Willem Elfrink - $150K in BEAT purchases and sales in the last 12 months
- Alison A. Cornell - $100K in ZIVO purchases and sales in the last 12 months
- John Bernard Payne - $100K in ZIVO purchases and sales in the last 12 months
- Richard Ferrari - $96K in BEAT purchases and sales in the last 12 months
- Laith L. Yaldoo - $65K in ZIVO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark E. Strome?
Mark E. Strome is a corporate insider, tracked as 10% Owner of Zivo Bioscience, Inc. (ZIVO). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mark E. Strome last file a Form 4?
The most recent primary Form 4 on record is dated 24 April 2026, one of 8 filings going back to 2024.
Has Mark E. Strome been buying or selling stock?
Recorded transactions: 8 open-market purchases ($2.76M) and 1 open-market sale ($895K) across all tracked filings.
